Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -682.0% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 23.9 | n/a |
Pr/Book | 2.1 |
Latest | F'cast | |
---|---|---|
Revenue | 43.4% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 1.79 | (16.27) | (23.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2.57 | (50.08) | (63.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Ondine’s APDT reduces SARS-CoV-2 infectivity | 31-Jan-2023 | 12:01 | RNS |
TR-1: Notification of major holdings | 17-Jan-2023 | 10:04 | RNS |
Second Price Monitoring Extn | 13-Jan-2023 | 16:40 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 19.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 54.00 |
52 Week Low | 17.50 |
Volume | 73,070 |
Shares Issued | 194.59m |
Market Cap | £37.95m |
Beta | 0.00 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:51 | 22,500 @ 19.50p |
15:30 | 40,000 @ 19.49p |
14:29 | 10,000 @ 19.47p |
10:00 | 70 @ 19.89p |
08:00 | 500 @ 20.00p |
Chair | Jean Charest |
CEO | Carolyn Cross |
You are here: research